Cosmo Pharmaceuticals N.V (C43) — Working Capital to Net Assets Ratio
Cosmo Pharmaceuticals N.V (C43) has a Working Capital to Net Assets ratio of 32.2% as of December 2025. Working capital of €157.76 Million (current assets of €183.28 Million minus current liabilities of €25.52 Million) is measured against net assets of €489.18 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Cosmo Pharmaceuticals N.V balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cosmo Pharmaceuticals N.V Working Capital to Net Assets (2016–2025)
This chart shows how Cosmo Pharmaceuticals N.V's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 32.2%, reflecting working capital of €157.76 Million against net assets of €489.18 Million EUR. Check tangible net worth ratio of Cosmo Pharmaceuticals N.V to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Cosmo Pharmaceuticals N.V (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cosmo Pharmaceuticals N.V from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Cosmo Pharmaceuticals N.V (C43) market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 32.2% | €157.76 Million | €489.18 Million | €183.28 Million | €25.52 Million | ▲ +1.8 pp |
| 2024 | 30.5% | €153.99 Million | €505.09 Million | €202.26 Million | €48.27 Million | ▲ +11.4 pp |
| 2023 | 19.1% | €77.11 Million | €403.62 Million | €102.23 Million | €25.11 Million | ▼ -4.9 pp |
| 2022 | 24.0% | €111.15 Million | €463.79 Million | €306.10 Million | €194.95 Million | ▼ -25.7 pp |
| 2021 | 49.7% | €254.61 Million | €512.68 Million | €275.85 Million | €21.24 Million | ▼ -8.1 pp |
| 2020 | 57.8% | €231.07 Million | €400.12 Million | €252.87 Million | €21.79 Million | ▼ -15.1 pp |
| 2019 | 72.8% | €286.66 Million | €393.73 Million | €302.37 Million | €15.71 Million | ▼ -7.9 pp |
| 2018 | 80.7% | €358.82 Million | €444.85 Million | €374.17 Million | €15.35 Million | ▲ +42.8 pp |
| 2017 | 37.8% | €177.87 Million | €470.12 Million | €197.31 Million | €19.43 Million | ▼ -2.7 pp |
| 2016 | 40.5% | €168.36 Million | €415.56 Million | €187.07 Million | €18.72 Million | — |